Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Dec;90(12):1490-4.
doi: 10.1136/bjo.2006.098855. Epub 2006 Aug 9.

Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial

K F Damji  1 , A M Bovell, W G Hodge, W Rock, K Shah, R Buhrmann, Y I Pan
Affiliations
Randomized Controlled Trial

Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial

K F Damji et al. Br J Ophthalmol. 2006 Dec.

Abstract

Aims: To compare selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT), in terms of intraocular pressure (IOP) lowering, in patients with open-angle glaucoma.

Methods: 176 eyes of 152 patients were enrolled in this study, 89 in the SLT and 87 in the ALT groups. Patients were randomised to receive either SLT or ALT treatment to 180 degrees of the trabecular meshwork. Patients were followed up to 12 months after treatment. The main outcome measured was IOP lowering at 12 months after treatment, compared between the SLT and ALT groups.

Results: No significant difference (p = 0.846) was found in mean decrease in IOP between the SLT (5.86 mm Hg) and ALT (6.04 mm Hg) groups at 1 year or at any other time points, nor were there any significant differences in the rate of early or late complications between the two groups.

Conclusions: SLT is equivalent to ALT in terms of IOP lowering at 1 year, and is a safe and effective procedure for patients with open-angle glaucoma.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no proprietary interest in the Selecta 7000 laser or in Lumenis

References

    1. Wise J B, Witter S L. Argon laser therapy for open angle glaucoma. Arch Ophthalmol 197997319–322. - PubMed
    1. The Glaucoma Laser Trial Research Group The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow up study: 7. Results. Am J Ophthamol 1995120718–731. - PubMed
    1. Latina M A, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 199560359–371. - PubMed
    1. Noecker R J, Kramer T R, Latina M.et al Comparison of acute morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty by electron microscopic evaluation. Invest Ophthalmol Vis Sci 19989S472
    1. Anderson R R, Parrish J A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983220524–527. - PubMed

Publication types